Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors (Q3300940): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors | |||
Revision as of 16:53, 24 October 2021
Project Q3300940 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors |
Project Q3300940 in Germany |
Statements
3,277.91 Euro
0 references
409,739.1 Euro
0 references
0.8 percent
0 references
1 October 2020
0 references
30 September 2022
0 references
AmpliVak Immunotherapy GmbH
0 references
Hennigsdorf, Stadt
0 references
Identifiers
DE_TEMPORARY_3742
0 references